Stockreport

Humacyte outlines 12-month cash runway and accelerates Symvess adoption following $56.5M capital raise [Seeking Alpha]

Humacyte, Inc.  (HUMA) 
PDF Laura Niklason, Founder, President, CEO & Director, highlighted significant progress in the commercial launch of Symvess, reporting "product sales improved to $703,000, [Read more]